Get informed when a big investor buys or sells
+ FollowOvervalued by 72.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $30.14 Million |
|---|---|
| Enterprise Value | $23.73 Million |
| Earnings per Share | $0.02 |
| Beta | 2.82 |
| Outstanding Shares | 62,829,725 |
| P/E Ratio | -7.98 |
|---|---|
| PEG | 1.6 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.72 |
| Enterprise Value to EBIT | -4.4 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 7.43% |
|---|---|
| Total Invested | $9,848▼ 99.79% |
| Investors Holding | 1▼ 20.00% |
Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, loc...
Stockcircle shows 5 open-market insider sales for Health In Tech in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.